Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cohn

Showing results (721-730 of 730) with videos related to

Pageof 73
Sort By:
You have reached the last page of results.This site can display upto 730 results.
Brain : a Journal of Neurology|February 4, 2012
The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansionsJavier Simón-Sánchez, Elise G P Dopper, Petra E Cohn-Hokke, et al.
AIDS (London, England)|March 15, 2024
Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trialTrevor A Crowell, Justin Ritz, Lu Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial)Husam A Alqaisi, David E Cohn, Jing-Yi Chern, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 7, 2011
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal statusSteven J Skates, Phuong Mai, Nora K Horick, et al.
Molecular Syndromology|June 7, 2012
Update on Kleefstra SyndromeM H Willemsen, A T Vulto-van Silfhout, W M Nillesen, et al.
Genes & Development|August 26, 2015
Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivoEnrico Caserta, Onur Egriboz, Hui Wang, et al.
Gynecologic Oncology|March 19, 2023
Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysisTheodore M Brasky, Erinn M Hade, David E Cohn, et al.
Plos One|July 28, 2016
Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation CarriersElena Vigorito, Karoline B Kuchenbaecker, Jonathan Beesley, et al.
Plos Genetics|April 2, 2013
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskFergus J Couch, Xianshu Wang, Lesley McGuffog, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 73

Showing results (721-730 of 730) with videos related to

Sort By:
Pageof 73
You have reached the last page of results.This site can display upto 730 results.
Brain : a Journal of Neurology|February 4, 2012
The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansionsJavier Simón-Sánchez, Elise G P Dopper, Petra E Cohn-Hokke, et al.
AIDS (London, England)|March 15, 2024
Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trialTrevor A Crowell, Justin Ritz, Lu Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial)Husam A Alqaisi, David E Cohn, Jing-Yi Chern, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 7, 2011
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal statusSteven J Skates, Phuong Mai, Nora K Horick, et al.
Molecular Syndromology|June 7, 2012
Update on Kleefstra SyndromeM H Willemsen, A T Vulto-van Silfhout, W M Nillesen, et al.
Genes & Development|August 26, 2015
Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivoEnrico Caserta, Onur Egriboz, Hui Wang, et al.
Gynecologic Oncology|March 19, 2023
Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysisTheodore M Brasky, Erinn M Hade, David E Cohn, et al.
Plos One|July 28, 2016
Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation CarriersElena Vigorito, Karoline B Kuchenbaecker, Jonathan Beesley, et al.
Plos Genetics|April 2, 2013
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskFergus J Couch, Xianshu Wang, Lesley McGuffog, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 73